相关实验视频
Updated: Jul 2, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
使用MiniMedTM 780G自动化胰岛素输送系统安全地炼
David N O'Neal1,2,3, Dessi P Zaharieva4, Dale Morrison1,2,3
1Department of Medicine, The University of Melbourne, Parkville, Australia.
Diabetes technology & therapeutics
|February 20, 2024
概括
患有1型糖尿病 (T1D) 的人可以使用MiniMedTM 780G自动胰岛素输送 (AID) 系统更安全地炼. 遵循胰岛素和碳水化合物管理指南,可以改善身体活动期间的葡萄糖控制.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 运动生理学 运动生理学
背景情况:
- 运动为1型糖尿病 (T1D) 患者提供了显著的身体和心理益处.
- 葡萄糖不稳定性和在运动期间监测葡萄糖水平的挑战限制了T1D患者的运动参与.
- 自动胰岛素输送系统 (AID) 可以改善运动期间的血糖控制,但受到皮下胰岛素药理学的限制.
研究的目的:
- 评估MiniMedTM 780G AID系统在运动期间控制T1D患者血糖水平的有效性.
- 用MiniMedTM 780G系统提供安全炼的实用策略.
主要方法:
- 在运动期间使用MiniMedTM 780G系统对T1D患者血糖控制数据的分析.
- 应用于运动管理的共识指南,包括机上胰岛素,碳水化合物摄入量和胰岛素减少.
- 案例研究说明了使用该设备炼的实用方法.
主要成果:
- 当MiniMedTM 780G系统与计划的炼和遵守指导方针一起使用时,它实现了在范围内的%时间和范围以下的%时间的目标.
- 该系统调整基础胰岛素的能力,并结合自动校正螺栓,有助于葡萄糖稳定.
- 尽管皮下胰岛素的药理动力学限制,该装置在维持血糖控制方面表现出有效性.
结论:
- MiniMedTM 780G AID系统为患有T1D的人提供了一种可行的安全炼选择.
- 实施胰岛素和碳水化合物管理的特定策略对于使用AID系统优化运动期间的葡萄糖控制至关重要.
- 虽然存在局限性,但MiniMedTM 780G系统增强了T1D患者安全有效炼的能力.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
172
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
172
Insulin Formulations: Types and Delivery
196
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
196
Hypoglycemia and Glucagon
262
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
262
Diabetes: Management and Pharmacotherapy
283
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
283
Oral Hypoglycemic Agents: Glinides
154
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
154
Assessing Blood pressure in the Leg
2.5K
Proper measurement of leg blood pressure is a critical skill for healthcare providers, ensuring precise and reliable readings. When performed correctly, this procedure informs patient care and enhances the efficacy of interventions. The following text outlines step-by-step guidelines to measure blood pressure in the leg, providing clarity and ease of understanding for practitioners.
Preparation:
Preparation:
2.5K

